We are live on
!
Find out more
Avior Wealth Management Portfolio holdings
AUM
$3.79B
Turnover
13.85%
1-Year Est. Return
15.36%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+15.36%
3 Year Est. Return
+71.45%
5 Year Est. Return
+69.28%
10 Year Est. Return
+233.16%
AUM
$1.21B
AUM Growth
-$1.74M
(-0.14%)
Cap. Flow
-$86.6M
Cap. Flow
% of AUM
-7.16%
Top 10 Holdings %
Top 10 Hldgs %
30.82%
Holding
1,276
New
120
Increased
303
Reduced
337
Closed
75
Avg Time Held
2.8
years
Top 10 Avg Time Held
3.6
years
Top 20 Avg Time Held
3.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.12M |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
+$4.8M |
| 3 |
Procter & Gamble
PG
|
+$3.26M |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$2.14M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$1.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Broad Market ETF
SCHB
|
+$19.3M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$17.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$16.7M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$10.7M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 63.45% |
| 2 | Financials | 8.03% |
| 3 | Technology | 7.73% |
| 4 | Healthcare | 4.9% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Sherwin-Williams
SHW
$81.8B
| $850K | 0.07% |
2,415
+2,408
| +34,400% | +$778K |
2019 Q3
9 quarters
|
|
227
Ascendis Pharma A/S
ASND
$14.9B
| $840K | 0.07% |
6,251
+1,447
| +30% | +$215K |
2020 Q1
7 quarters
|
|
228
Dentsply Sirona
XRAY
$1.76B
| $836K | 0.07% |
15,000
+1,600
| +12% | +$88K |
2021 Q3
1 quarter
|
|
229
iShares Select Dividend ETF
DVY
$23B
| $830K | 0.07% |
6,773
+40
| +0.6% | +$4.77K |
2013 Q4
32 quarters
|
|
230
Factset
FDS
$10.7B
| $813K | 0.07% |
1,674
| – | – |
2017 Q4
16 quarters
|
|
231
Omnicom Group
OMC
$22.1B
| $813K | 0.07% |
11,109
-53
| -0.5% | -$3.77K |
2014 Q1
31 quarters
|
|
232
Vulcan Materials
VMC
$32.7B
| $811K | 0.07% |
3,907
| – | – |
2019 Q2
10 quarters
|
|
233
F5
FFIV
$25.9B
| $810K | 0.07% |
3,312
-428
| -11% | -$95K |
2020 Q3
5 quarters
|
|
234
DELISTED
Blueprint Medicines
BPMC
| $808K | 0.07% |
7,549
-288
| -4% | -$30.1K |
2018 Q3
13 quarters
|
|
235
TransUnion
TRU
$14.2B
| $806K | 0.07% |
6,805
| – | – |
2017 Q4
16 quarters
|
|
236
Unilever
UL
$139B
| $801K | 0.07% |
13,244
| – | – |
2021 Q1
3 quarters
|
|
237
Progressive
PGR
$124B
| $797K | 0.07% |
7,771
| – | – |
2017 Q4
16 quarters
|
|
238
Chubb
CB
$136B
| $786K | 0.07% |
4,073
-1,096
| -21% | -$206K |
2017 Q3
17 quarters
|
|
239
Saia
SAIA
$9.08B
| $781K | 0.06% |
2,318
| – | – |
2021 Q2
2 quarters
|
|
240
National Vision
EYE
$1.4B
| $772K | 0.06% |
16,102
| – | – |
2020 Q4
4 quarters
|
|
241
Nice
NICE
$6.73B
| $768K | 0.06% |
2,531
| – | – |
2020 Q3
5 quarters
|
|
242
Stanley Black & Decker
SWK
$14B
| $765K | 0.06% |
4,063
+700
| +21% | +$129K |
2014 Q1
31 quarters
|
|
243
Neurocrine Biosciences
NBIX
$13.9B
| $764K | 0.06% |
8,971
+835
| +10% | +$76.8K |
2019 Q4
8 quarters
|
|
244
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$7.15B
| $760K | 0.06% |
25,006
+8
| +0% | +$244 |
2018 Q1
15 quarters
|
|
245
Tapestry
TPR
$23.8B
| $749K | 0.06% |
18,467
+1
| +0% | +$41 |
2021 Q2
2 quarters
|
|
|
SBNY
246
DELISTED
Signature Bank
SBNY
| $748K | 0.06% |
2,315
-268
| -10% | -$83.5K |
2021 Q1
3 quarters
|
|
247
The Kraft Heinz Company
KHC
$27.6B
| $743K | 0.06% |
20,740
+14,482
| +231% | +$520K |
2015 Q4
24 quarters
|
|
248
Philip Morris
PM
$312B
| $737K | 0.06% |
7,767
| – | – |
2014 Q1
31 quarters
|
|
249
DELISTED
TopBuild
BLD
| $730K | 0.06% |
2,649
| – | – |
2019 Q2
10 quarters
|
|
250
General Motors
GM
$73.4B
| $729K | 0.06% |
12,461
-931
| -7% | -$54.4K |
2013 Q4
32 quarters
|
|
Similar funds
Avior Wealth Management's Q4 2021 Portfolio in Review
As of Q4 2021, Avior Wealth Management held 1,276 positions worth $1.21B, down 0.14% from $1.21B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Avior Wealth Management withdrew a net $86.6M in Q4 2021, closing 75 positions and reducing 337 holdings. Its most notable exit was Acceleron Pharma, an estimated $940K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, down from 66% a quarter earlier, followed by Financials and Technology.
Against the trend, Avior Wealth Management opened a new position in U.S. Small Cap Portfolio ETF Class Shares worth $934K.
- Avior Wealth Management's largest Q4 2021 buy was U.S. Small Cap Portfolio ETF Class Shares: 15,582 shares worth $934K.
- Avior Wealth Management added most to Vanguard Morningstar Growth ETF in Q4 2021, an estimated $6.12M increase.
- Avior Wealth Management's biggest Q4 2021 reduction was Schwab US Broad Market ETF, cutting an estimated $19.3M.
- Avior Wealth Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $940K.
- Avior Wealth Management's ten largest holdings make up 31% of its $1.21B portfolio in Q4 2021.
- Avior Wealth Management opened 120 new positions and closed 75 in Q4 2021.
- Avior Wealth Management's portfolio value fell 0.14% quarter-over-quarter to $1.21B.
Based on Avior Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.